Scarica l'app Stockscreener
1,076.98
0.50%
5.34
Dopo l'orario di chiusura:
1077.97
0.99
+0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$1,071.64
Aprire:
$1074.64
Volume 24 ore:
932.85K
Relative Volume:
0.25
Capitalizzazione di mercato:
$963.92B
Reddito:
$59.42B
Utile/perdita netta:
$18.41B
Rapporto P/E:
53.26
EPS:
20.2197
Flusso di cassa netto:
$6.44B
1 W Prestazione:
+3.38%
1M Prestazione:
+0.64%
6M Prestazione:
+38.42%
1 anno Prestazione:
+35.36%
Intervallo 1D:
$1,072.71
$1,085.73
Intervallo di 1 settimana:
$1,039.54
$1,088.48
Portata 52W:
$623.78
$1,111.99
Lilly Eli Co Stock (LLY) Company Profile
Nome
Lilly Eli Co
Settore
Industria
Telefono
(317) 276-2000
Indirizzo
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Confronta LLY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LLY
Lilly Eli Co
|
1,076.98 | 959.14B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.78 | 495.78B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
229.89 | 404.36B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
138.88 | 266.96B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
106.45 | 260.71B | 63.90B | 19.05B | 13.05B | 7.5596 |
Lilly Eli Co Stock (LLY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2025-12-15 | Reiterato | BofA Securities | Buy |
| 2025-12-15 | Reiterato | Goldman | Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-11-10 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-10-20 | Reiterato | BMO Capital Markets | Outperform |
| 2025-10-14 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-08-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2025-08-18 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-06-05 | Downgrade | Erste Group | Buy → Hold |
| 2025-04-28 | Downgrade | HSBC Securities | Buy → Reduce |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-09-13 | Ripresa | Citigroup | Buy |
| 2024-08-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-02-21 | Downgrade | DZ Bank | Buy → Hold |
| 2024-02-16 | Reiterato | Morgan Stanley | Overweight |
| 2023-12-21 | Downgrade | Daiwa Securities | Buy → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-10-20 | Ripresa | UBS | Buy |
| 2023-08-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-07-26 | Reiterato | Citigroup | Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | UBS | Buy |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-06 | Iniziato | Jefferies | Hold |
| 2023-02-15 | Downgrade | Societe Generale | Hold → Sell |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-09-22 | Aggiornamento | UBS | Neutral → Buy |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2022-03-10 | Iniziato | Daiwa Securities | Outperform |
| 2022-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
| 2022-01-03 | Reiterato | Bernstein | Mkt Perform |
| 2021-12-17 | Iniziato | Goldman | Neutral |
| 2021-12-16 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-16 | Reiterato | BofA Securities | Buy |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-10-11 | Aggiornamento | Berenberg | Hold → Buy |
| 2021-09-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-05 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-06-24 | Reiterato | Cantor Fitzgerald | Overweight |
| 2021-01-19 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-11-10 | Ripresa | Bernstein | Mkt Perform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-09-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-21 | Downgrade | UBS | Buy → Neutral |
| 2020-04-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-06 | Iniziato | Mizuho | Neutral |
| 2019-12-18 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Buy |
| 2019-05-28 | Iniziato | Goldman | Buy |
| 2019-04-24 | Aggiornamento | Edward Jones | Hold → Buy |
| 2019-04-11 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-03-12 | Iniziato | JP Morgan | Overweight |
| 2019-01-23 | Iniziato | UBS | Buy |
| 2018-11-26 | Downgrade | Citigroup | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2018-10-09 | Iniziato | Guggenheim | Buy |
| 2018-10-01 | Reiterato | SunTrust | Buy |
| 2018-09-26 | Ripresa | JP Morgan | Overweight |
Mostra tutto
Lilly Eli Co Borsa (LLY) Ultime notizie
Eli Lilly (LLY) Stock: Key News, Catalysts, Forecasts and Risks to Watch Before the Dec. 26, 2025 Market Open - ts2.tech
Eli Lilly’s Stock Holds Firm in the Weight-Loss Market Battle - AD HOC NEWS
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? - The Motley Fool
Eli Lilly (LLY) Stock After Hours Today (Dec. 25, 2025): Holiday Pause, GLP‑1 Catalysts, and What to Watch Before the Market Opens Dec. 26 - ts2.tech
Plancorp LLC Sells 1,287 Shares of Eli Lilly and Company $LLY - MarketBeat
OLD National Bancorp IN Has $479 Million Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Valuation Under Scrutiny Amid Shifting Competitive Landscape - AD HOC NEWS
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever - The Motley Fool
Eli Lilly (LLY) Stock After Hours on Dec. 24, 2025: Christmas Eve Close, GLP‑1 Headlines, and What to Watch Before Markets Reopen - ts2.tech
NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly? - Yahoo Finance
Check out Eli Lilly and's stock price (LLY-CA) in real time - CNBC
Eli Lilly (LLY) a Top Stock Split Candidate in 2026 - TipRanks
Eli Lilly (LLY) Bolsters Position in India's Obesity Drug Market - GuruFocus
HBK Sorce Advisory LLC Boosts Stock Position in Eli Lilly and Company $LLY - MarketBeat
16,522 Shares in Eli Lilly and Company $LLY Bought by Roffman Miller Associates Inc. PA - MarketBeat
Eli Lilly and Company $LLY Stock Position Decreased by Exchange Traded Concepts LLC - MarketBeat
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market? - TipRanks
Lilly, Novo lock horns in India's obesity drug race - Reuters
Novo and Lilly: FDA Approval of Wegovy Pill Launches New Obesity Battle - Morningstar
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Benzinga
What's Going On With Eli Lilly Stock Today? - Benzinga
Eli Lilly Navigates Expansion and Intensifying Rivalry - AD HOC NEWS
Novo Nordisk Gets US Approval for Wegovy Obesity Pill - Bloomberg.com
3 Catalysts That Can Start An Eli Lilly Stock Rally - Forbes
The Zacks Analyst Blog Highlights Eli Lilly, Shell, ICICI Bank, Frequency Electronics and Vaso - Zacks Investment Research
Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma's 2026 Comeback - Benzinga
Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts - ts2.tech
Novo beats Lilly to first FDA-approved GLP-1RA pill for obesity - Yahoo Finance
Sarasin & Partners LLP Sells 97,438 Shares of Eli Lilly and Company $LLY - MarketBeat
Evanson Asset Management LLC Sells 972 Shares of Eli Lilly and Company $LLY - MarketBeat
Clarius Group LLC Sells 3,308 Shares of Eli Lilly and Company $LLY - MarketBeat
Brighton Jones LLC Grows Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company (NYSE:LLY) S&P 500 Chart Medical Scale - Kalkine Media
Eli Lilly and Company (NYSE:LLY) Shares Unloaded Rep. David Taylor - MarketBeat
Jim Cramer Says Eli Lilly's GLP-1 Pill Is "Going to Revolutionize Everything" - Finviz
Jim Cramer Says Eli Lilly’s GLP-1 Pill Is “Going to Revolutionize Everything” - Yahoo Finance
Eli Lilly Stock (LLY) After Hours Drops on Wegovy Pill Approval: What to Know Before the Market Opens Dec. 23, 2025 - ts2.tech
US regulators approve Wegovy pill for weight loss, giving Novo Nordisk an edge over Lilly - Indianapolis Business Journal
Top Analyst Reports for Eli Lilly, Shell & ICICI Bank - TradingView — Track All Markets
Jim Cramer Discusses Major Catalyst For Eli Lilly (LLY) - Insider Monkey
FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers - Yahoo Finance UK
Eli Lilly’s Strategic Pivot: Acquiring Immunology Assets to Diversify Beyond Obesity Drugs - AD HOC NEWS
Lilly vs Novo Nordisk. Why 2026 Could Redefine the Obesity Drug Market - GuruFocus
Eli Lilly seeks FDA approval for pill that maintains weight loss after Wegovy, Zepbound - Scripps News
BofA Maintains Buy on Eli Lilly (LLY), Expects 2027 Earnings to Fully Realize Value of Obesity Drug Launches - Insider Monkey
Eli Lilly and Company (LLY) Announces Updated Meaningful Data on Breast Cancer Treatment - Insider Monkey
KMG Fiduciary Partners LLC Purchases 1,659 Shares of Eli Lilly and Company $LLY - MarketBeat
Abivax soars on report of Eli Lilly meeting French officials over possible deal - Investing.com
3 Reasons Investors Love Eli Lilly (LLY) - Finviz
Eli Lilly’s Strategic Maneuvers: Positioning for Market Dominance in 2026 - AD HOC NEWS
Eli Lilly (LLY) Stock: What to Know Before the U.S. Market Opens on Dec. 22, 2025 - ts2.tech
Lilly Eli Co Azioni (LLY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):